Endo International PLC (NASDAQ:ENDP)

During the Trading Day
63.71 -0.31 / -0.48%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
63.71 0.00 / 0.00%
 
Volume: 104.1K
Intellipharmaceutics' Oxycodone Program to Prevent Overdose - Analyst Blog
5:55pm / Zacks.com
Gilead (GILD) Hits 52-Week High Thanks to Sovaldi - Analyst Blog
Aug 21 / Zacks.com
IGI, Laboratories, Inc. (IG) in Focus: Stock Rises 5.8% - Tale of the Tape
10:12am / Zacks.com
Alcobra Starts Patient Enrollment for Mid-Stage Study on MDX - Analyst Blog
Aug 20 / Zacks.com
Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog
Aug 27 / Zacks.com
Salix Pharmaceuticals Jumps on Takeover Rumours by Allergan - Analyst Blog
Aug 20 / Zacks.com
Catalyst Pharmaceutical Partners (CPRX) Worth Watching: Stock Up 10.3% - Tale of the ...
Aug 26 / Zacks.com
Salix Pharmaceuticals (SLXP) Jumps: Stock Moves 15.5% Higher - Tale of the Tape
Aug 20 / Zacks.com
OncoGenex's Custirsen Passes First Interim Futility Analysis - Analyst Blog
Aug 22 / Zacks.com
Falling Earnings Estimates Signal Weakness Ahead for Egalet (EGLT) - Tale of the Tape
Aug 20 / Zacks.com
Auxilium Pharmaceuticals Up on Mid-Stage Data on Xiaflex - Analyst Blog
Aug 22 / Zacks.com
Why Enzymotec (ENZY) Could Be Positioned for a Slump - Tale of the Tape
Aug 20 / Zacks.com
AstraZeneca Updates on PLATO Study Investigation on Brilinta - Analyst Blog
Aug 22 / Zacks.com
Apricus Biosciences' ED Treatment Vitaros Now in Germany - Analyst Blog
Aug 19 / Zacks.com
Supernus' Trokendi XR Faces Generic Threat from Actavis - Analyst Blog
Aug 22 / Zacks.com
AstraZeneca's Asthma Drug in Focus, Phase III Study Initiated - Analyst Blog
Aug 18 / Zacks.com
Lannett Updates on Digoxin Safety Issues, Expands Portfolio - Analyst Blog
Aug 22 / Zacks.com
AstraZeneca's Gout Drug in Focus with Phase III Data Readout - Analyst Blog
Aug 15 / Zacks.com
Flamel Technologies SA (FLML) in Focus: Stock Rises 8% - Tale of the Tape
Aug 22 / Zacks.com
Merck KGaA Q2 Earnings Slip Y/Y, 2014 Sales View Confirmed - Analyst Blog
Aug 15 / Zacks.com
Astellas-Basilea's Isavuconazole Accepted for EU Review - Analyst Blog
Aug 21 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.